Quantitative analysis of topoisomerase IIalpha to rapidly evaluate cell proliferation in brain tumors

Biochem Biophys Res Commun. 2005 Jun 17;331(4):971-6. doi: 10.1016/j.bbrc.2005.03.224.

Abstract

Immunohistochemical cell proliferation analyses have come into wide use for evaluation of tumor malignancy. Topoisomerase IIalpha (topo IIalpha), an essential nuclear enzyme, has been known to have cell cycle coupled expression. We here show the usefulness of quantitative analysis of topo IIalpha mRNA to rapidly evaluate cell proliferation in brain tumors. A protocol to quantify topo IIalpha mRNA was developed with a real-time RT-PCR. It took only 3 h to quantify from a specimen. A total of 28 brain tumors were analyzed, and the level of topo IIalpha mRNA was significantly correlated with its immuno-staining index (p<0.0001, r=0.9077). Furthermore, it sharply detected that topo IIalpha mRNA decreased in growth-inhibited glioma cell. These results support that topo IIalpha mRNA may be a good and rapid indicator to evaluate cell proliferate potential in brain tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / analysis*
  • Antigens, Neoplasm / genetics
  • Brain Neoplasms / enzymology
  • Brain Neoplasms / pathology*
  • Cell Line, Tumor
  • Cell Proliferation*
  • Child, Preschool
  • DNA Topoisomerases, Type II / analysis*
  • DNA Topoisomerases, Type II / genetics
  • DNA-Binding Proteins / analysis*
  • DNA-Binding Proteins / genetics
  • Female
  • Glioma / enzymology
  • Glioma / pathology*
  • Humans
  • Immunohistochemistry
  • Male
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Antigens, Neoplasm
  • DNA-Binding Proteins
  • RNA, Messenger
  • DNA Topoisomerases, Type II